What it does
The National Disability Insurance Scheme (Becoming a Participant) Rules 2016 (the Rules) are legislative instruments made under ss 22, 23, 25, 27 and 209 of the National Disability Insurance Scheme Act 2013 (the Act). Their substantive function is to flesh out the access criteria that the CEO of the National Disability Insurance Agency (NDIA) must apply when deciding whether a person becomes a participant.
Part 2.4 states that a person meets the access criteria if the CEO is satisfied that the person meets the age requirements (Part 3), the residence requirements (Part 4) and either the disability requirements (Part 5) or the early intervention requirements (Part 6) as those requirements apply in the area in which the person resides. A person becomes a participant on the day the CEO makes a positive decision (para 2.3).
The Rules do not create new eligibility categories; they interpret and operationalise the statutory language. For the disability requirements, para 5.1 reproduces s 24 of the Act and then supplies binding rules on two critical elements: permanence (paras 5.4–5.7) and substantially reduced functional capacity (para 5.8). Permanence is defined negatively: an impairment is permanent only if there are no known, available and appropriate evidence-based clinical, medical or other treatments likely to remedy it (para 5.4). The Rules expressly contemplate fluctuating or degenerative conditions (paras 5.2, 5.5, 5.7) and permit ongoing treatment after permanency has been established (para 5.6).
For early intervention, the Rules implement s 25. They prohibit access where the CEO is satisfied that supports are more appropriately funded by another service system (para 6.1). Where the early intervention gateway is available, the Rules set out when the CEO is taken to be satisfied that early intervention will deliver the statutory benefits (paras 6.8–6.11). Children under six with developmental delay (as defined in s 9 of the Act) receive a deeming provision (para 6.10). Children with listed conditions published by the CEO need no further evidence (para 6.11).